Canandaigua National Corp’s Idexx Laboratories IDXX Stock Holding History

Canandaigua National Corp’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$546K	Buy	+971	New	+$623K	0.05%	225

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Canandaigua National Corp's IDXX Position: Q1 2026 in Review

Canandaigua National Corp opened a new position in Idexx Laboratories (IDXX) in Q1 2026: 971 shares worth $546K. The stake represents 0.05% of the portfolio and ranks #225 among its holdings.

1,314 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

Canandaigua National Corp held 971 shares of Idexx Laboratories worth $546K as of Q1 2026.
Idexx Laboratories was a new Canandaigua National Corp position in Q1 2026.
Idexx Laboratories made up 0.05% of Canandaigua National Corp's portfolio in Q1 2026, its #225 holding.
1,314 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Canandaigua National Corp's 13F filing for Q1 2026, filed 8 Apr 2026.